Mise à niveau vers Pro

Aquaculture Vaccines Market to Reach USD 4.2 Bn by 2031 as mRNA and Oral Vaccines Replace Antibiotics

[Hyderabad, April 17th, 2025] – The Aquaculture Vaccines Market, valued at 1.8 billion in 2023, will grow at 11.2% to 4.2 billion by 2031, as fish farms adopt advanced immunization, reports ClearView Market Insights.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-aquaculture-vaccines-market/   

2024 Industry Milestones

  1. mRNA Breakthroughs
    • Elanco's water-delivered mRNA vaccine prevents 95% of TiLV cases.
    • RNAi-based shrimp vaccines enter commercial trials.
  2. Needle-Free Revolution
    • PHARMAQ's oral vaccine survives digestive acids to trigger immunity.
    • Yeast-vectored vaccines provide 3x longer protection.
  3. Climate Adaptation
    • Thermostable vaccines withstand 30°C without refrigeration.
    • Saline-tolerant formulations work across water types.

Regional Leaders

  • Europe (40%): Norway vaccinates 100% of farmed salmon.
  • Asia-Pacific (XX%): Vietnam's shrimp vaccine mandate.
  • Americas (XX%): Chile's USD 1B+ vaccinated salmon industry.

Executive Insights
"We're vaccinating fish more precisely than humans now – with mRNA and oral tech."
– Jeff Simmons, CEO, Elanco

Roadmap to 2031

  • 2025: 50% of shrimp farms transition from antibiotics to vaccines.
  • 2027: mRNA vaccines cover 30% of salmon production.
  • 2030: Universal fish vaccines targeting multiple pathogens expected.

For more insights, visit https://clearviewmarketinsights.com/report-store  

 

About ClearView Market Insights

ClearView Market Insights analyzes more than 80 animal health markets, spanning from livestock to aquaculture.

 

Media contact:

Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: 
sales@clearviewmarketinsights.com
Phone: +1 917-993-7369